
IQVIA Holdings IQV
$ 171.5
-0.97%
Quarterly report 2026-Q1
added 05-05-2026
IQVIA Holdings Depreciation & Amortization 2011-2026 | IQV
Annual Depreciation & Amortization IQVIA Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.14 B | 1.11 B | 1.12 B | 1.13 B | 1.26 B | 1.29 B | 1.2 B | 1.14 B | 1.01 B | 289 M | 128 M | 121 M | 108 M | 98.3 M | 92 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.29 B | 92 M | 750 M |
Quarterly Depreciation & Amortization IQVIA Holdings
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 288 M | - | 276 M | 265 M | - | 278 M | 269 M | 264 M | - | 297 M | 259 M | 253 M | - | 248 M | 270 M | 255 M | - | 336 M | 343 M | 323 M | - | 319 M | 308 M | 316 M | - | 299 M | 294 M | 295 M | - | 283 M | 282 M | 282 M | - | 256 M | 245 M | 232 M | - | 34 M | 32 M | 32 M | - | 32.9 M | 30 M | 30.3 M | - | 30.2 M | 29.8 M | 29.1 M | - | 27.3 M | 25 M | 24.6 M | - | 25.7 M | 23.7 M | 23.3 M | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 343 M | 23.3 M | 192 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Castle Biosciences
CSTL
|
40.8 M | $ 20.03 | 4.32 % | $ 581 M | ||
|
Fulgent Genetics
FLGT
|
24.9 M | $ 16.41 | 2.88 % | $ 496 M | ||
|
Guardant Health
GH
|
39.7 M | $ 114.97 | 17.09 % | $ 14.4 B | ||
|
ICON Public Limited Company
ICLR
|
488 M | $ 115.09 | 1.36 % | $ 9.49 B | ||
|
Interpace Biosciences
IDXG
|
425 K | $ 1.8 | - | $ 7.96 M | ||
|
Agilent Technologies
A
|
321 M | $ 113.78 | 2.96 % | $ 34.6 B | ||
|
Illumina
ILMN
|
354 M | $ 141.92 | 0.17 % | $ 22.6 B | ||
|
Celcuity
CELC
|
167 K | $ 140.34 | 7.16 % | $ 6.56 B | ||
|
Co-Diagnostics
CODX
|
1.11 M | $ 2.39 | 21.32 % | $ 3.18 M | ||
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
15 M | $ 21.15 | 3.02 % | $ 1.13 B | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
70.1 M | $ 96.09 | 3.44 % | $ 6.49 B | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 421.87 | 0.47 % | $ 12.2 B | ||
|
Mettler-Toledo International
MTD
|
51.1 M | $ 1 082.67 | 3.04 % | $ 22.3 B | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
National Research Corporation
NRC
|
7.62 M | $ 19.26 | 2.72 % | $ 431 M | ||
|
Natera
NTRA
|
16.7 M | $ 204.92 | 4.53 % | $ 20.2 B | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
Personalis
PSNL
|
10 M | $ 7.95 | 12.93 % | $ 709 M | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 156.03 | 2.36 % | $ 7.73 B | ||
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
36.1 M | $ 8.9 | 6.08 % | $ 1.14 B | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
53.7 M | $ 3.81 | 7.32 % | $ 353 M | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
Koninklijke Philips N.V.
PHG
|
1.12 B | $ 26.74 | 2.65 % | $ 25.4 B | ||
|
Thermo Fisher Scientific
TMO
|
1.05 B | $ 451.79 | 0.89 % | $ 170 B | ||
|
Senseonics Holdings
SENS
|
1.51 M | $ 5.71 | 3.07 % | $ 238 M | ||
|
Twist Bioscience Corporation
TWST
|
24.9 M | $ 53.66 | 8.4 % | $ 3.21 B | ||
|
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
2.02 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
87 K | $ 2.35 | -1.26 % | $ 5.4 M | ||
|
Laboratory Corporation of America Holdings
LH
|
681 M | $ 257.42 | 1.47 % | $ 21.4 B | ||
|
Waters Corporation
WAT
|
88.1 M | $ 341.32 | 2.42 % | $ 20.3 B | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
119 M | $ 8.83 | 5.75 % | $ 1.92 B | ||
|
Quest Diagnostics Incorporated
DGX
|
570 M | $ 193.75 | 1.92 % | $ 21.5 B |